Dalmay T., and Edwards D.R. MicroRNAs and the hallmarks of cancer. Oncogene 25 (2006) 6170-6175
Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
Hwang H.W., and Mendell J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 96 Suppl (2007) R40-R44
Suarez Y., and Sessa W.C. MicroRNAs as novel regulators of angiogenesis. Circ. Res. 104 (2009) 442-454
Pulkkinen K., Malm T., Turunen M., Koistinaho J., and Yla-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett. 582 (2008) 2397-2401
Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000) 389-395
Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., and Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
Helisch A., and Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10 (2003) 83-97
Griffioen A.W., and Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52 (2000) 237-268
Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
Ribatti D., Vacca A., and Presta M. The discovery of angiogenic factors: a historical review. Gen. Pharmacol. 35 (2000) 227-231
Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat. Rev. Drug Discov. 6 (2007) 273-286
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29 (2002) 15-18
Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev., Mol. Cell Biol. 8 (2007) 464-478
Carthew R.W., and Sontheimer E.J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136 (2009) 642-655
Winter J., Jung S., Keller S., Gregory R.I., and Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11 (2009) 228-234
Hock J., and Meister G. The Argonaute protein family. Genome Biol. 9 (2008) 210
Filipowicz W., Bhattacharyya S.N., and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 9 (2008) 102-114
Brodersen P., Sakvarelidze-Achard L., Bruun-Rasmussen M., Dunoyer P., Yamamoto Y.Y., Sieburth L., and Voinnet O. Widespread translational inhibition by plant miRNAs and siRNAs. Science 320 (2008) 1185-1190
Brodersen P., and Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev. Mol. Cell Biol. 10 (2009) 141-148
Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., and Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (2005) 769-773
John B., Enright A.J., Aravin A., Tuschl T., Sander C., and Marks D.S. Human microRNA targets. PLoS Biol. 2 (2004) e363
Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798
Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., and Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 37 (2005) 495-500
Wienholds E., Koudijs M.J., van Eeden F.J., Cuppen E., and Plasterk R.H. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat. Genet. 35 (2003) 217-218
Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., Mills A.A., Elledge S.J., Anderson K.V., and Hannon G.J. Dicer is essential for mouse development. Nat. Genet. 35 (2003) 215-217
Yang W.J., Yang D.D., Na S., Sandusky G.E., Zhang Q., and Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 280 (2005) 9330-9335
Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., Kang Y.J., Jiang Z., Du X., Cook R., Das S.C., Pattnaik A.K., Beutler B., and Han J. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27 (2007) 123-134
Suarez Y., Fernandez-Hernando C., Pober J.S., and Sessa W.C. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100 (2007) 1164-1173
Shilo S., Roy S., Khanna S., and Sen C.K. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 471-477
Kuehbacher A., Urbich C., Zeiher A.M., and Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101 (2007) 59-68
Suarez Y., Fernandez-Hernando C., Yu J., Gerber S.A., Harrison K.D., Pober J.S., Iruela-Arispe M.L., Merkenschlager M., and Sessa W.C. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 14082-14087
Ruby J.G., Jan C.H., and Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 448 (2007) 83-86
Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., and Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108 (2006) 3068-3071
Wurdinger T., Tannous B.A., Saydam O., Skog J., Grau S., Soutschek J., Weissleder R., Breakefield X.O., and Krichevsky A.M. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14 (2008) 382-393
Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M.C., and Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283 (2008) 15878-15883
Chen C., Chai H., Wang X., Jiang J., Jamaluddin M.S., Liao D., Zhang Y., Wang H., Bharadwaj U., Zhang S., Li M., Lin P., and Yao Q. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood 112 (2008) 3205-3216
Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., and Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1516-1521
Wang S., Aurora A.B., Johnson B.A., Qi X., McAnally J., Hill J.A., Richardson J.A., Bassel-Duby R., and Olson E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15 (2008) 261-271
Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y., and Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15 (2008) 272-284
Kuhnert F., Mancuso M.R., Hampton J., Stankunas K., Asano T., Chen C.Z., and Kuo C.J. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135 (2008) 3989-3993
van Solingen C., Seghers L., Bijkerk R., Duijs J.M., Roeten M.K., van Oeveren-Rietdijk A.M., Baelde H.J., Monge M., Vos J.B., de Boer H.C., Quax P.H., Rabelink T.J., and van Zonneveld A.J. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J. Cell Mol. Med. 13 (2009) 1577-1585
Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., Brownstein M.J., Tuschl T., and Margalit H. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33 (2005) 2697-2706
Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., and Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2999-3004
Baskerville S., and Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11 (2005) 241-247
le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafre S.A., Farace M.G., and Agami R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26 (2007) 3699-3708
Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., and Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 1 (2006) e116
Koff A. How to decrease p27Kip1 levels during tumor development. Cancer Cell 9 (2006) 75-76
Matsui J., Wakabayashi T., Asada M., Yoshimatsu K., and Okada M. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J. Biol. Chem. 279 (2004) 18600-18607
Li Y., Song Y.H., Li F., Yang T., Lu Y.W., and Geng Y.J. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 381 (2009) 81-83
Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., and Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94 (1994) 2036-2044
Murohara T., Witzenbichler B., Spyridopoulos I., Asahara T., Ding B., Sullivan A., Losordo D.W., and Isner J.M. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1156-1161
Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., and Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101 (1998) 731-736
Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J.F., Fishman M.C., Huang P.L., and Isner J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101 (1998) 2567-2578
Tuccoli A., Poliseno L., and Rainaldi G. miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation. Cell Cycle 5 (2006) 2473-2476
Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133 (2008) 217-222
Taguchi A., Yanagisawa K., Tanaka M., Cao K., Matsuyama Y., Goto H., and Takahashi T. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res. 68 (2008) 5540-5545
Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., Furth E.E., Lee W.M., Enders G.H., Mendell J.T., and Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38 (2006) 1060-1065
Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A.M., and Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324 (2009) 1710-1713
Otsuka M., Zheng M., Hayashi M., Lee J.D., Yoshino O., Lin S., and Han J. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J. Clin. Invest. 118 (2008) 1944-1954
Chen Y., and Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111 (2008) 1217-1226
Qian L.W., Xie J., Ye F., and Gao S.J. Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J. Virol. 81 (2007) 7001-7010
Tsai Y.H., Wu M.F., Wu Y.H., Chang S.J., Lin S.F., Sharp T.V., and Wang H.W. The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J. Virol. 83 (2009) 622-632
Wang X.H., Qian R.Z., Zhang W., Chen S.F., Jin H.M., and Hu R.M. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 36 (2009) 181-188
Kuehbacher A., Urbich C., and Dimmeler S. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol. Sci. 29 (2008) 12-15
Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3627-3632
Weber M.J. New human and mouse microRNA genes found by homology search. FEBS J. 272 (2005) 59-73
Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., and Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 281 (2006) 18277-18284
Martin M.M., Buckenberger J.A., Jiang J., Malana G.E., Nuovo G.J., Chotani M., Feldman D.S., Schmittgen T.D., and Elton T.S. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J. Biol. Chem. 282 (2007) 24262-24269
Otani A., Takagi H., Suzuma K., and Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ. Res. 82 (1998) 619-628
Camps C., Buffa F.M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A.L., Gleadle J.M., and Ragoussis J. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14 (2008) 1340-1348
Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
Ebos J.M., Lee C.R., Cruz-Munoz W., Bjarnason G.A., Christensen J.G., and Kerbel R.S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15 (2009) 232-239
Paez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vinals F., Inoue M., Bergers G., Hanahan D., and Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15 (2009) 220-231
Neri D., and Bicknell R. Tumour vascular targeting. Nat. Rev. Cancer 5 (2005) 436-446
Thijssen V.L., Postel R., Brandwijk R.J., Dings R.P., Nesmelova I., Satijn S., Verhofstad N., Nakabeppu Y., Baum L.G., Bakkers J., Mayo K.H., Poirier F., and Griffioen A.W. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15975-15980
Thijssen V.L., van Beijnum J.R., Mayo K.H., and Griffioen A.W. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango. Curr. Pharm. Des. 13 (2007) 3576-3583
van Beijnum J.R., van der Linden E., and Griffioen A.W. Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics. Exp. Cell Res. 314 (2008) 264-272
Pasqualini R., and Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 380 (1996) 364-366
Griffioen A.W. Therapeutic approaches of angiogenesis inhibition: are we tackling the problem at the right level?. Trends Cardiovasc. Med. 17 (2007) 171-176
Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., Elbashir S., Geick A., Hadwiger P., Harborth J., John M., Kesavan V., Lavine G., Pandey R.K., Racie T., Rajeev K.G., Rohl I., Toudjarska I., Wang G., Wuschko S., Bumcrot D., Koteliansky V., Limmer S., Manoharan M., and Vornlocher H.P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
Whitehead K.A., Langer R., and Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8 (2009) 129-138
Brandwijk R.J., Griffioen A.W., and Thijssen V.L. Targeted gene-delivery strategies for angiostatic cancer treatment. Trends Mol. Med. 13 (2007) 200-209
Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry Jr. W.T., Carter B.S., Krichevsky A.M., and Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10 (2008) 1470-1476
Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
Davis S., Lollo B., Freier S., and Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 34 (2006) 2294-2304
Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., and Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456 (2008) 980-984
Kedde M., Strasser M.J., Boldajipour B., Oude Vrielink J.A., Slanchev K., le Sage C., Nagel R., Voorhoeve P.M., van Duijse J., Orom U.A., Lund A.H., Perrakis A., Raz E., and Agami R. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131 (2007) 1273-1286
Ketting R.F. A dead end for microRNAs. Cell 131 (2007) 1226-1227
Elmen J., Lindow M., Schutz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjarn M., Hansen H.F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E.M., and Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 452 (2008) 896-899
Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., and Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 (2006) 87-98
Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., and David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449 (2007) 919-922